Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial)
Circulation · 09.07.2024 · 150 (2) · 91-101
DOI: 10.1161/circulationaha.124.068938 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 09.07.2024. Verfasst von Heerajnarain Bulluck und 33 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Teaching Hospital, National Health Service Trust, United Kingdom (H.B.). Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction, Adenosine Monophosphate. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOH | National Medical Research Council, EU-CARDIOPROTECTION, EU-METAHEART.
Abstract (Originalsprache)
BACKGROUND: The administration of intravenous cangrelor at reperfusion achieves faster onset of platelet P2Y12 inhibition than oral ticagrelor and has been shown to reduce myocardial infarction (MI) size in the preclinical setting. We hypothesized that the administration of cangrelor at reperfusion will reduce MI size and prevent microvascular obstruction in patients with ST-segment–elevation MI undergoing primary percutaneous coronary intervention. METHODS: This was a phase 2, multicenter, randomized, double-blind, placebo-controlled clinical trial conducted between November 2017 to November 2021 in 6 cardiac centers in Singapore. Patients were randomized to receive either cangrelor or placebo initiated before the primary percutaneous coronary intervention procedure on top of oral ticagrelor. The key exclusion criteria included presenting
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leeds Teaching Hospital, National Health Service Trust, United Kingdom (H.B.).
- Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, United Kingdom (H.B.).
- Department of Cardiology (J.H.C., J.B., C.Y.C., S.T.L., V.P., X.M.P., J.C.K.T., A.W., Y.K.K., J.W.C.T.), National Heart Centre Singapore.
- Cardiovascular & Metabolic Disorders Program (J.H.C., M.C., D.J.H.), Duke-National University of Singapore Medical School.
- Department of Emergency Medicine, Sengkang General Hospital, Singapore (A.A., S.H.L., B.P.T.).
- Department of Cardiology, National University Heart Centre Singapore (P.C., C.-H.L., M.Y.C.).
ORCID-Profile: Heerajnarain Bulluck, Jennifer Bryant, Ping Chai, Ashish Chawla, Fei Gao, Andrew Fu Wah Ho, John Hoe, Syed Saqib Imran, Chi-Hang Lee, Soo Teik Lim, Swee Han Lim, Patrick Lim Zhan Yun, Valeria Paradies, Xuan Ming Pung, Julian Cheong Kiat Tay, Lynette Teo, Aaron Wong, Evelyn Wong, Mark Y Chan, Jack W C Tan
Förderung
- MOH | National Medical Research Council
- EU-CARDIOPROTECTION
- EU-METAHEART
Zitieren
APA
Bulluck, H., Chong, J. H., Bryant, J., Annathurai, A., Chai, P., Chan, M., Chawla, A., Chin, C. Y., Chung, Y. C., Gao, F., Ho, H. H., Ho, A. F. W., Hoe, J., Imran, S. S., Lee, C. H., Lim, B., Lim, S. T., Lim, S. H., Liew, B. W., …, & PITRI Investigators (2024). Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial). Circulation, 150(2), 91-101. https://doi.org/10.1161/circulationaha.124.068938
Vancouver
Bulluck H, Chong JH, Bryant J, Annathurai A, Chai P, Chan M, et al. Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial). Circulation. 2024;150(2):91-101. doi:10.1161/circulationaha.124.068938
BibTeX
@article{Bulluck2024,
author = {Bulluck, Heerajnarain and Chong, Jun Hua and Bryant, Jennifer and Annathurai, Annitha and Chai, Ping and Chan, Mervyn and Chawla, Ashish and Chin, Chee Yang and Chung, Yiu-Cho and Gao, Fei and Ho, Hee Hwa and Ho, Andrew Fu Wah and Hoe, John and Imran, Syed Saqib and Lee, Chi-Hang and Lim, Benji and Lim, Soo Teik and Lim, Swee Han and Liew, Boon Wah and Zhan Yun, Patrick Lim and Ong, Marcus Eng Hock and Paradies, Valeria and Pung, Xuan Ming and Tay, Julian Cheong Kiat and Teo, Lynette and Ting, Boon Ping and Wong, Aaron and Wong, Evelyn and Watson, Timothy and Chan, Mark Y and Keong, Yeo Khung and Tan, Jack W C and Hausenloy, Derek J and PITRI Investigators, PITRI Investigators},
title = {Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial)},
journal = {Circulation},
year = {2024},
volume = {150},
number = {2},
pages = {91--101},
doi = {10.1161/circulationaha.124.068938}
}
EUVIMED